IR@PKUHSC  > 北京大学第二临床医学院  > 心血管内科
学科主题临床医学
Efficacy and Tolerability of Long-Acting Nifedipine GITS/OROS Monotherapy or Combination Therapy in Hypertensive Patients Results of a 12-Week International, Prospective, Multicentre, Observational Study
Ueng, Kwo-Chang1; Sun Ningling2; Abd El Maksod3; Hung, Kuan-Yu4; Yin Yuehui5
刊名CLINICAL DRUG INVESTIGATION
2011
31期:9页:631-642
收录类别SCI
文章类型Article
WOS标题词Science & Technology
类目[WOS]Pharmacology & Pharmacy
研究领域[WOS]Pharmacology & Pharmacy
关键词[WOS]CONTROLLED-RELEASE NIFEDIPINE ; BLOOD-PRESSURE ; CARDIOVASCULAR-DISEASE ; POSTMARKETING SURVEILLANCE ; CHINESE PATIENTS ; ANGINA-PECTORIS ; ASIA-PACIFIC ; GITS ; MANAGEMENT ; SYSTEM
英文摘要

Background: Achieving the maximum reduction in cardiovascular morbidity and mortality is the primary goal of blood pressure (BP) control. Current guidelines recommend several antihypertensive classes as first-line therapy for this purpose but the decision on which agent/s to use will likely be based upon the treating physician′s clinical experience. Observational studies provide a useful way of ascertaining the efficacy and tolerability of an antihypertensive in a real-life clinical setting.

Objective: The aim of this observational study was to determine the efficacy, tolerability and physician/patient satisfaction with long-acting nifedipine (gastrointestinal therapeutic system [GITS]/osmotic-controlled release oral delivery system [OROS]) in a large multinational cohort of hypertensive patients.

Methods: This observational study was conducted in adults (aged >= 18 years) with previously untreated or treated hypertension. The decision to prescribe nifedipine 30 or 60 mg once daily was made by the treating physician. Patients then attended up to three clinic visits any time over a 12-week period when medication could be up- or down-titrated or switched. The mean reduction in systolic BP (SBP)/diastolic BP (DBP) from first visit and whether target BP (<140/<90 mmHg or <130/<80 mmHg [for patients with diabetes mellitus]) had been achieved were recorded at the final visit and stratified according to hypertension grade and presence of cardiovascular risk factors. Subjective assessment of efficacy was reported by physicians and patients. All adverse events and their possible relationship to study drug were recorded. All assessments were performed on patients who received at least one dose of nifedipine GITS/OROS.

Results: A total of 14 344 patients received nifedipine GITS/OROS treatment (58.7% male; 77.7% non-diabetic; mean age 57.5 years); 14 266 had at least one follow-up visit over a mean 10.2-week period, and 8000 patients had three visits over a mean 12-week period. Initially, 12 826 (89.4%) patients received nifedipine 30 mg, and 6912 patients (48.2%) overall received concomitant antihypertensive agents. The overall mean reduction in SBP/DBP was -27.7/-14.1 mmHg; BP reduction was linked to hypertension grade, age, the presence of five or more cardiovascular risk factors, and prior treatment. Target BP was achieved in 2485/7432 patients (33.4%) receiving nifedipine GITS/OROS monotherapy and in 1751/6912 (25.3%) receiving combination therapy (i.e. GITS/OROS plus any other antihypertensive agent). Non-diabetic patients with moderate (n = 3413) and high (n=1138) risk reached their target BP goal in 62.5% and 54.2% of cases, respectively; the corresponding values in diabetic patients (moderate-added risk n = 8; high-added risk n = 684) were 75.0% and 54.8%, respectively. A total of 229 patients (1.6%) reported experiencing 286 adverse events. Physician/patient satisfaction with treatment was high.

Conclusion: Long-acting nifedipine GITS/OROS, alone or in combination with other antihypertensive agents, provides effective and well tolerated treatment of hypertension in a broad spectrum of patients routinely seen in day-to-day clinical practice.

语种英语
WOS记录号WOS:000294700600003
资助机构Bayer Schering Pharma, Leverkusen, Germany
引用统计
被引频次:4[WOS]   [WOS记录]     [WOS相关记录]
文献类型期刊论文
条目标识符http://ir.bjmu.edu.cn/handle/400002259/67691
专题北京大学第二临床医学院_心血管内科
作者单位1.Dr Erfan & Bagedo Gen Hosp, Jeddah, Saudi Arabia
2.Chung Shan Med Univ, Inst Med, Sch Med, Chung Shan Med Univ Hosp,Dept Internal Med, Taichung 402, Taiwan
3.Peking Univ, Peoples Hosp, Dept Cardiol, Beijing 100871, Peoples R China
4.Natl Taiwan Univ, Coll Med, Natl Taiwan Univ Hosp, Clin Dept Internal Med, Taipei 10764, Taiwan
5.Chongqing Med Univ, Affiliated Hosp 2, Chongqing, Peoples R China
推荐引用方式
GB/T 7714
Ueng, Kwo-Chang,Sun Ningling,Abd El Maksod,et al. Efficacy and Tolerability of Long-Acting Nifedipine GITS/OROS Monotherapy or Combination Therapy in Hypertensive Patients Results of a 12-Week International, Prospective, Multicentre, Observational Study[J]. CLINICAL DRUG INVESTIGATION,2011,31(9):631-642.
APA Ueng, Kwo-Chang,Sun Ningling,Abd El Maksod,Hung, Kuan-Yu,&Yin Yuehui.(2011).Efficacy and Tolerability of Long-Acting Nifedipine GITS/OROS Monotherapy or Combination Therapy in Hypertensive Patients Results of a 12-Week International, Prospective, Multicentre, Observational Study.CLINICAL DRUG INVESTIGATION,31(9),631-642.
MLA Ueng, Kwo-Chang,et al."Efficacy and Tolerability of Long-Acting Nifedipine GITS/OROS Monotherapy or Combination Therapy in Hypertensive Patients Results of a 12-Week International, Prospective, Multicentre, Observational Study".CLINICAL DRUG INVESTIGATION 31.9(2011):631-642.
条目包含的文件
条目无相关文件。
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Ueng, Kwo-Chang]的文章
[Sun Ningling]的文章
[Abd El Maksod]的文章
百度学术
百度学术中相似的文章
[Ueng, Kwo-Chang]的文章
[Sun Ningling]的文章
[Abd El Maksod]的文章
必应学术
必应学术中相似的文章
[Ueng, Kwo-Chang]的文章
[Sun Ningling]的文章
[Abd El Maksod]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。